Septerna (SEPN) Gains from Investment Securities (2023 - 2026)
Septerna (SEPN) recorded quarterly Gains from Investment Securities of -$3000.0 in Q1 2026, up 99.77% quarter-over-quarter from -$1.3 million in Q4 2025, and down 100.99% on a YoY basis from $304400.0 in Q1 2025.
Septerna (SEPN) Gains from Investment Securities (2023 - 2026) Analysis & Trends
Septerna's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at -$3000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 100.99% year-over-year to -$3000.0; the TTM figure through Mar 2026 stood at -$13.5 million (down 4550.07% YoY), while the FY2025 annual figure was $4.4 million, up 48.98% from the prior year.
- Gains from Investment Securities was -$3000.0 for Q1 2026 at Septerna, up from -$1.3 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $12.6 million in Q4 2023 to a low of -$12.2 million in Q4 2024.
- Historically, Gains from Investment Securities has averaged $429766.6 across 4 years, with a median of $23227.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities slumped 197.19% in 2024, then jumped 18489.68% in 2025.
- A 4-year view of Gains from Investment Securities shows it stood at $12.6 million in 2023, then sank by 197.19% to -$12.2 million in 2024, then surged by 89.37% to -$1.3 million in 2025, then soared by 99.77% to -$3000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$3000.0 (Q1 2026), -$1.3 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -1.30 Mn |
| Dec 31, 2025 | -1.30 Mn |
| Sep 30, 2025 | 4.32 Mn |
| Sep 30, 2025 | 4.32 Mn |
| Jun 30, 2025 | 590,988.00 |
| Jun 30, 2025 | 590,988.00 |
| Mar 31, 2025 | 304,400.00 |
| Mar 31, 2025 | 304,400.00 |
| Dec 31, 2024 | -12.23 Mn |
| Dec 31, 2024 | -12.23 Mn |
| Sep 30, 2024 | 23,227.00 |
| Sep 30, 2024 | 23,227.00 |
| Jun 30, 2024 | 23,227.00 |
| Jun 30, 2024 | 23,227.00 |
| Mar 31, 2024 | -13,000.00 |
| Mar 31, 2024 | -13,000.00 |
| Dec 31, 2023 | 12.58 Mn |
| Dec 31, 2023 | 12.58 Mn |